Immunological effects of BCG in malignant melanoma: two modes of administration compared.
D000941:Antigens; D001500:BCG Vaccine / Q000008:administration & dosage; D005121:Extremities; D006386:Hemagglutination Tests; D006801:Humans; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000032:analysis; D007958:Leukocyte Count; D008214:Lymphocytes / Q000276:immunology; D008545:Melanoma / Q000628:therapy*; D008722:Methods; D012075:Remission, Spontaneous; D012878:Skin Neoplasms / Q000628:therapy*; D012882:Skin Tests
D000941:Antigens; D001500:BCG Vaccine; D007136:Immunoglobulins